Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Ont Health Technol Assess Ser ; 15(8): 1-67, 2015.
Article in English | MEDLINE | ID: mdl-26366242

ABSTRACT

BACKGROUND: Pulmonary rehabilitation (PR) is a comprehensive intervention of exercise training, education, and behaviour change to improve the physical and psychological condition of people with chronic respiratory disorders, such as chronic obstructive pulmonary disease (COPD) and to promote long-term adherence to health-enhancing behaviours. Although PR is considered the standard of care for patients with COPD who remain symptomatic despite bronchodilator therapies, current evidence suggests that only 1.15% of COPD patients across Canada have access to PR facilities for care. OBJECTIVES: The objectives of this study were to identify the number of health care facilities across Ontario providing PR services for patients with COPD, describe the scope of those services, and determine the province's current capacity to provide PR services relative to need, for the province as a whole and by local health integration network (LHIN). METHODS: The Pulmonary Rehabilitation Programs in Ontario (PRO) Survey was a province-wide, descriptive, cross-sectional survey of health care facilities (hospitals, family health teams, and community health centres). It was distributed to 409 facilities to collect information on various aspects of PR services in the province. RESULTS: Between April 2013 and February 2014, 187 facilities responded to the survey (46% response rate). Most responding centres (144) did not offer PR services, and only 43 were full PR sites providing a comprehensive program. Hospital-based programs made up the majority of sites offering full PR services (67%), followed by programs based at family health teams (19%) and community health centres (14%). More than 90% of PR programs are outpatient-based. The average wait time for outpatient PR was 6.9 weeks, and 58% of programs provide services 5 days per week. More than 80% of patients attending PR complete the full program. Across all program types, the total estimated provincial capacity for PR outpatient care is 4,524 patients per year, or 0.66% to 1.78% of patients with COPD, depending on the estimated prevalence of disease. LIMITATIONS: These results are representative of 12 of the 14 LHINs in Ontario due to low response rates in facilities in 2 LHINs. CONCLUSIONS: Although some increase in capacity has occurred since a similar survey in 2005, PR resources in Ontario are insufficient to support the delivery of care to people with COPD in accordance with clinical practice guideline recommendations.


Subject(s)
Health Services Accessibility , Health Services , Pulmonary Disease, Chronic Obstructive/rehabilitation , Ambulatory Care , Cross-Sectional Studies , Health Care Surveys , Humans , Ontario
2.
Parasitology ; 139(2): 244-7, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22018291

ABSTRACT

A traditional assumption is that schistosome cercariae lose their tails at the onset of penetration. It has, however, recently been demonstrated that, for Schistosoma mansoni, cercarial tails were not invariably being shed as penetration took place and a high proportion of tails entered human skin under experimental conditions. This phenomenon was termed delayed tail loss (DTL). In this paper, we report that DTL also happens with S. japonicum cercariae during penetration of mouse skin. It occurred at all cercarial densities tested, from as few as 10 cercariae/2·25 cm(2) of mouse skin up to 200 cercariae. Furthermore, it was demonstrated that there was a density-dependent increase in DTL as cercarial densities increased. No such density-dependent enhancement was shown for percentage attachment over the same cercarial density range.


Subject(s)
Schistosoma japonicum/physiology , Skin/parasitology , Animals , Cercaria/physiology , Female , Mice , Mice, Inbred BALB C , Tissue Culture Techniques
3.
J Palliat Med ; 14(2): 185-9, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21254814

ABSTRACT

BACKGROUND: One measure of quality hospice care is minimization of hospitalization. Few studies have explored reasons for hospitalization and characteristics of care received by hospice patients in the hospital. OBJECTIVES: To characterize the experience of hospice patients in the hospital and determine factors associated with high intensiveness of care. DESIGN: Retrospective review of patient medical records in the Mayo Hospice Program in 2007. RESULTS: Of 263 hospice patients, 17% were hospitalized in 2007. Of those hospitalized, 42% percent died in the hospital. Average length of stay was 4 days. Almost half were admitted through the emergency department. Common reasons for admission included delirium, pain, and falls. Most patients (52%) received care of a moderate level of intensity, with 18% receiving the most intensive level of care. Receiving care of high intensity was associated with emergency department admission. Charges to patient accounts averaged over $9,000 per stay. Concordance of care in the hospital to preexisting patient goals was high, but could not be determined in 39% of cases due to lack of documentation of patient goals. CONCLUSIONS: Hospitalization of hospice patients is costly to the health care system. Most care was of low or moderate intensiveness. Quality improvements focusing on concise communication of patient goals and prevention of pain, delirium, and falls have the potential for the greatest impact on reducing hospitalizations and minimizing care that is discordant with patient goals.


Subject(s)
Hospice Care , Hospitalization , Inpatients , Aged , Critical Care/statistics & numerical data , Female , Hospitalization/economics , Hospitalization/statistics & numerical data , Humans , Male , Medical Audit , Minnesota , Retrospective Studies
4.
J Ethnopharmacol ; 123(3): 475-82, 2009 Jun 25.
Article in English | MEDLINE | ID: mdl-19473794

ABSTRACT

AIM OF STUDY: This study screened for anthelmintic and/or antitumour bioactive compounds from Thai indigenous plants and evaluated effectiveness against three different worm species and two cancer cell lines. MATERIALS AND METHODS: Methylene chloride and methanol extracts of 32 plant species were screened for in vitro anthelmintic activity against three species of worms, the nematode Caenorhabditis elegans, the digeneans Paramphistomum epiclitum and Schistosoma mansoni (cercariae). Cytotoxicity of the extracts was evaluated against two cancer cell lines: human amelanotic melanoma (C32) and human cervical carcinoma (HeLa) by the SRB assay. Anthelmintic and anticancer activities were evaluated by the inhibiting concentration at 50% death (IC(50)) and the selectivity index (SI) relative to human fibroblasts. RESULTS AND CONCLUSIONS: None of the extracts were active against Paramphistomum epiclitum. Plumbagin, a pure compound from Plumbago indica, had the strongest activity against Caenorhabditis elegans. The methylene chloride extract of Piper chaba fruits had the strongest activity against schistosome cercariae. Strong cytotoxicity was shown by the methylene chloride extract of Michelia champaca bark and the methanol extract of Curcuma longa rhizome against C32 and HeLa, respectively. These extracts had higher SI (>100) than positive controls in relation to either the worms or the cell lines. The methanol extract of Bouea burmanica had a slightly lower activity towards C32 cells than did Michelia champaca but had a much higher SI (>27,000). ETHNOPHARMACOLOGICAL RELEVANCE: The plant species screened in this research was recorded by several indigenous medicinal practitioners as antiparasitic, anticancer and/or related activities to the human major organ system.


Subject(s)
Anthelmintics/therapeutic use , Antineoplastic Agents, Phytogenic/therapeutic use , Magnoliopsida , Plant Extracts/therapeutic use , Plants, Medicinal , Animals , Anthelmintics/pharmacology , Antineoplastic Agents, Phytogenic/pharmacology , Caenorhabditis elegans/drug effects , Cell Line, Tumor , Drug Screening Assays, Antitumor , Female , Fibroblasts/drug effects , Humans , Inhibitory Concentration 50 , Medicine, Traditional , Melanoma/drug therapy , Paramphistomatidae/drug effects , Phytotherapy , Plant Extracts/pharmacology , Schistosoma mansoni/drug effects , Skin Neoplasms/drug therapy , Thailand , Uterine Cervical Neoplasms/drug therapy
5.
Electrophoresis ; 29(15): 3201-6, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18633941

ABSTRACT

Schistosoma mansoni infection in mice has been fingerprinted using CE to study the capabilities of this technique as a diagnostic tool for this parasitic disease. Two modes of separation were used in generating the electrophoretic data, with each untreated urine sample the following methods were applied: (i) a fused-silica capillary, operating with an applied potential of 18 kV, in micellar EKC (MEKC) and (ii) a polyacrylamide-coated capillary, operating with an applied potential of -20 kV under zonal CZE conditions. By combining normal and reverse polarities in the data treatment we have extracted more information from the samples, which is a better approach for CE metabolomics. The traditional problems associated with variability in electrophoretic peak migration times for analytes were countered by using a dynamic programming algorithm for the electropherograms alignment. Principal component analyses of these aligned electropherograms and partial least square discriminant analysis (PLS-DA) data are shown to provide a valuable means of rapid and sample classification. This approach may become an important tool for the identification of biomarkers, diagnosis and disease surveillance.


Subject(s)
Electrophoresis, Capillary/methods , Metabolomics , Schistosoma mansoni/isolation & purification , Schistosomiasis mansoni/diagnosis , Urinalysis/methods , Acrylic Resins , Animals , Biomarkers , Female , Least-Squares Analysis , Mice , Micelles , Pilot Projects , Principal Component Analysis , Schistosoma mansoni/metabolism , Schistosomiasis mansoni/parasitology , Schistosomiasis mansoni/urine , Sensitivity and Specificity , Silicon Dioxide , Time Factors
6.
Int J Pharm ; 301(1-2): 129-39, 2005 Sep 14.
Article in English | MEDLINE | ID: mdl-16019171

ABSTRACT

The model penetrants butyl paraben (BP), methyl paraben (MP) and caffeine (CF), because of their different octanol/water partition coefficients and postulated routes of permeation through human skin, were selected to assess the enhancing activity of pre-treatment solutions consisting of monounsaturated (oleic (OA) and palmitoleic (PA)) and poly-unsaturated (linoleic (LA)) fatty acids in benzyl alcohol (BA) using Franz diffusion cells and HPLC detection. Prior to assessing the effect of penetrant lipophilicity, MP was chosen to investigate the concentration-dependent effect of fatty acids in pre-treatment solutions. At 5% (w/w) fatty acids in BA, only pre-treatment solutions containing palmitoleic acid (PA) increased the permeation of MP when compared to pre-treatment with BA alone, whereas at higher concentrations (10 and 20%, w/w), all pre-treatment solutions except 10% OA produced a significant increase in MP flux (P<0.05). The general order of fatty acid effectiveness at any concentration was PA>LA>OA. At 20% (w/w) fatty acids in BA, all pre-treatment solutions significantly enhanced the permeation of all three penetrants (P<0.05) and an inverse relationship between penetrant lipophilicity and enhancement effect was observed. The permeation of BP was enhanced to a similar extent by all three fatty acids, whereas PA caused a significantly greater enhancement in the flux of both MP and CF when compared to OA, LA and controls (P<0.05). It was proposed that the synergetic enhancement mechanisms of fatty acids and BA in pre-treatment solutions were augmenting the polar route by way of interactions with both polar and non-polar regions of stratum corneum lipids. Furthermore, the combination of PA and BA appears to be a good candidate as a penetration enhancer for hydrophilic molecules.


Subject(s)
Benzyl Alcohol/pharmacology , Caffeine/pharmacokinetics , Central Nervous System Stimulants/pharmacokinetics , Fatty Acids, Unsaturated/pharmacology , Parabens/pharmacokinetics , Skin Absorption/drug effects , Algorithms , Chemical Phenomena , Chemistry, Physical , Chromatography, High Pressure Liquid , Chromatography, Thin Layer , Diffusion Chambers, Culture , Female , Humans , In Vitro Techniques , Middle Aged , Permeability , Pharmaceutic Aids , Solutions
8.
Bull. W.H.O. (Print) ; 53(1): 55-65, 1976.
Article in English | WHO IRIS | ID: who-260873
SELECTION OF CITATIONS
SEARCH DETAIL
...